Neogen (NEOG) Share-based Compensation (2010 - 2026)
Neogen's (NEOG) quarterly Share-based Compensation came in at $1.2 million in Q1 2026, down 71.43% year-on-year from $4.2 million in Q1 2025, and down 72.09% quarter-over-quarter from $4.3 million in Q4 2025.
Neogen (NEOG) Share-based Compensation (2010 - 2026) Analysis & Trends
Neogen's Share-based Compensation history runs 17 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- On a quarterly basis, Share-based Compensation fell 71.43% year-over-year to $1.2 million in Q1 2026; TTM through Feb 2026 was $20.7 million, a 58.89% increase from a year earlier, with the FY2025 full-year figure at $17.3 million, up 19.85% from the prior year.
- Share-based Compensation retreated to $1.2 million in Q1 2026 per NEOG's latest filing, from $4.3 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $10.3 million in Q2 2025 and bottomed at -$7.3 million in Q2 2023.
- The 5-year median for Share-based Compensation is $2.8 million (2023), against an average of $2.8 million.
- Across the five-year window, Share-based Compensation sank 446.66% in 2023 and surged 46677.27% in 2025, its largest moves.
- Year by year, Share-based Compensation stood at $2.6 million in 2022, then soared by 33.14% to $3.5 million in 2023, then surged by 36.71% to $4.8 million in 2024, then slipped by 10.42% to $4.3 million in 2025, then plunged by 72.09% to $1.2 million in 2026.
- Per Business Quant, the three latest NEOG Share-based Compensation figures stand at $1.2 million (Q1 2026), $4.3 million (Q4 2025), and $4.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1.20 Mn |
| Feb 28, 2026 | 1.20 Mn |
| Nov 30, 2025 | 4.30 Mn |
| Nov 30, 2025 | 4.30 Mn |
| Aug 31, 2025 | 4.90 Mn |
| Aug 31, 2025 | 4.90 Mn |
| May 31, 2025 | 10.29 Mn |
| May 31, 2025 | 10.29 Mn |
| Feb 28, 2025 | 4.20 Mn |
| Feb 28, 2025 | 4.20 Mn |
| Nov 30, 2024 | 4.80 Mn |
| Nov 30, 2024 | 4.80 Mn |
| Aug 31, 2024 | 4.00 Mn |
| Aug 31, 2024 | 4.00 Mn |
| May 31, 2024 | 22,000.00 |
| May 31, 2024 | 22,000.00 |
| Feb 29, 2024 | 3.75 Mn |
| Feb 29, 2024 | 3.75 Mn |
| Nov 30, 2023 | 3.51 Mn |
| Nov 30, 2023 | 3.51 Mn |